Logo
x

Search

Subscribe Now

Harmony Biosciences

Harmony Biosciences Expands its CNS Pipeline Through the Acquisition of Epygenix Therapeutics

Harmony Biosciences Expands its CNS Pipeline Through the Acquisition of Epygenix Therapeutics

  • May 1, 2024
Harmony Biosciences Collaborates with Bioprojet to Develop TPM-1116 as a Treatment of Narcolepsy and Other Sleep/Wake Disorders

Harmony Biosciences Collaborates with Bioprojet to Develop TPM-1116 as a Treatment of Narcolepsy and Other Sleep/Wake Disorders

  • April 12, 2024
Harmony Biosciences to Acquire Zynerba for ~$200M

Harmony Biosciences to Acquire Zynerba for ~$200M

  • August 17, 2023
Harmony Biosciences Reports the Initiation of P-III (INTUNE) Withdrawal Study for Pitolisant to Treat Idiopathic Hypersomnia

Harmony Biosciences Reports the Initiation of P-III (INTUNE) Withdrawal Study for Pitolisant to Treat Idiopathic Hypersomnia

  • April 28, 2022
Insights+: The US FDA New Drug Approvals in August 2019

Insights+: The US FDA New Drug Approvals in August 2019

  • September 20, 2019
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.